Pharmather Holdings Ltd (PHRM)

Currency in CAD
0.45
+0.07(+18.42%)
Closed·
PHRM Scorecard
Full Analysis
Stock has taken a big hit over the last week
Unusual trading volume
PHRM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.360.55
52 wk Range
0.150.77
Key Statistics
Bid/Ask
0.24 / 0.26
Prev. Close
0.24
Open
0.42
Day's Range
0.36-0.55
52 wk Range
0.15-0.77
Volume
1.15M
Average Volume (3m)
196.61K
1-Year Change
125%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHRM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Pharmather Holdings Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Pharmather Holdings Ltd Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen’s University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

0
Market
Canada

Compare PHRM to Peers and Sector

Metrics to compare
PHRM
Peers
Sector
Relationship
P/E Ratio
−27.7x−0.9x−0.5x
PEG Ratio
−0.350.000.00
Price/Book
33.6x0.8x2.6x
Price / LTM Sales
-0.4x3.3x
Upside (Analyst Target)
-57.1%40.6%
Fair Value Upside
Unlock5.5%5.3%Unlock

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PHRM Income Statement

FAQ

What Stock Exchange Does Pharmather Holdings Trade On?

Pharmather Holdings is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for Pharmather Holdings?

The stock symbol for Pharmather Holdings is "PHRM."

What Is the Pharmather Holdings Market Cap?

As of today, Pharmather Holdings market cap is 40.96M.

What Is Pharmather Holdings's Earnings Per Share (TTM)?

The Pharmather Holdings EPS (TTM) is -0.02.

When Is the Next Pharmather Holdings Earnings Date?

Pharmather Holdings will release its next earnings report on 24 Sept 2025.

From a Technical Analysis Perspective, Is PHRM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Pharmather Holdings Stock Split?

Pharmather Holdings has split 0 times.

How Many Employees Does Pharmather Holdings Have?

Pharmather Holdings has 0 employees.

What is the current trading status of Pharmather Holdings (PHRM)?

As of 15 Aug 2025, Pharmather Holdings (PHRM) is trading at a price of 0.45, with a previous close of 0.24. The stock has fluctuated within a day range of 0.36 to 0.55, while its 52-week range spans from 0.15 to 0.77.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.